Abate As Industries Ltd

Abate As Industries Ltd

₹ 9.59 -1.34%
17 Jul - close price
About

Incorporated in 1991, Abate As Industries
Ltd primarily operates in the eye healthcare segment through its super specialty hospitals
and optical outlets[1]

Key Points

Business Overview:[1]
AAIL is a multi-sector enterprise with a diverse portfolio in healthcare, education, retail, technology, real estate, and consultancy
services.

  • Market Cap 151 Cr.
  • Current Price 9.59
  • High / Low 26.2 / 8.00
  • Stock P/E 12.3
  • Book Value 11.0
  • Dividend Yield 0.00 %
  • ROCE 6.70 %
  • ROE 7.30 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Stock is trading at 0.87 times its book value
  • Debtor days have improved from 245 to 59.2 days.
  • Company's working capital requirements have reduced from 357 days to 75.1 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 32.4%
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
-0.00 -0.00 -0.00 14.09 41.06 42.13 42.69 33.94
0.04 0.03 0.02 13.28 38.56 38.28 38.76 30.84
Operating Profit -0.04 -0.03 -0.02 0.81 2.50 3.85 3.93 3.10
OPM % 5.75% 6.09% 9.14% 9.21% 9.13%
-0.00 -0.00 -0.00 0.97 0.51 1.13 0.06 0.53
Interest -0.00 -0.00 -0.00 0.06 0.11 0.17 0.15 0.13
Depreciation -0.00 -0.00 -0.00 0.55 0.49 0.52 0.52 0.52
Profit before tax -0.04 -0.03 -0.02 1.17 2.41 4.29 3.32 2.98
Tax % -0.00% -0.00% -0.00% -1.71% 6.64% 5.13% 8.43% 2.01%
-0.04 -0.03 -0.02 1.19 2.25 4.07 3.06 2.93
EPS in Rs -0.04 -0.03 -0.02 0.08 0.14 0.26 0.19 0.19
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
14 159
13 146
Operating Profit 1 13
OPM % 5% 8%
1 3
Interest 0 1
Depreciation 1 2
Profit before tax 1 13
Tax % -2% 5%
1 12
EPS in Rs 0.07 0.78
Dividend Payout % -0% -0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 1031%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 1018%
Stock Price CAGR
10 Years: 23%
5 Years: 26%
3 Years: 0%
1 Year: -58%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Equity Capital 79 158
Reserves 85 16
11 10
31 40
Total Liabilities 206 223
149 150
CWIP 0 -0
Investments 14 14
43 59
Total Assets 206 223

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
-1 6
-162 -3
165 -2
Net Cash Flow 2 1
Free Cash Flow -1 3
CFO/OP -91% 57%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025 Mar 2026
Debtor Days 430 59
Inventory Days 413 49
Days Payable 209 36
Cash Conversion Cycle 635 72
Working Capital Days 640 75
ROCE % 7%

Insights

In beta
Mar 2025 Mar 2026
Operational Eye Hospitals
count

Log in to view insights

Please log in to see hidden values.

Login
Planned Eye Hospitals (Target Network)
count
Educational Institutions
count
Healthcare Revenue Mix
% of consolidated revenue
Students Trained (Cumulative)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
31.87% 31.87% 31.87% 31.87% 31.87% 31.87% 31.87% 27.56% 27.57% 27.57% 27.57% 32.42%
68.12% 68.12% 68.14% 68.13% 68.13% 68.13% 68.14% 72.44% 72.43% 72.44% 72.44% 67.58%
No. of Shareholders 1,0911,0691,0501,0281,0101,0461,0501,0641,0502,4352,5803,030

Documents